Significant Ownership of STEMPOINT CAPITAL LP

Signature - Title
/s/ Sean C. Tan - Sean C. Tan, Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by STEMPOINT CAPITAL LP.

Notify me when STEMPOINT CAPITAL LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of STEMPOINT CAPITAL LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
XLO Xilio Therapeutics, Inc. Common stock, par value $0.0001 per share 8.4% $3,979,818 +$1,339,818 6,030,028 +51% StemPoint Capital LP 31 Dec 2025
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 7% $12,798,168 -$8,186,300 619,766 -39% StemPoint Capital LP 31 Dec 2025
VTGN Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share 1.5% $456,394 -$1,266,690 616,749 -74% StemPoint Capital LP 31 Dec 2025

Schedules 13D/G Reported by STEMPOINT CAPITAL LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.